OMNILIT ACQUISITION CORP-A (OLIT) Stock Fundamental Analysis

NASDAQ:OLIT • US68218C1080

8.44 USD
+0.5 (+6.3%)
At close: Nov 7, 2023
9.63 USD
+1.19 (+14.1%)
After Hours: 11/7/2023, 8:14:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OLIT. OLIT was compared to 0 industry peers in the Unkown industry. OLIT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OLIT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year OLIT was profitable.
  • In the past year OLIT has reported a negative cash flow from operations.
OLIT Yearly Net Income VS EBIT VS OCF VS FCFOLIT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 500K -500K

1.2 Ratios

Industry RankSector Rank
ROA 5.66%
ROE 6%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OLIT Yearly ROA, ROE, ROICOLIT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 -2 4 -4 6

1.3 Margins

  • OLIT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OLIT Yearly Profit, Operating, Gross MarginsOLIT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, OLIT has less shares outstanding
  • There is no outstanding debt for OLIT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OLIT Yearly Shares OutstandingOLIT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M
OLIT Yearly Total Debt VS Total AssetsOLIT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M

2.2 Solvency

  • An Altman-Z score of 37.80 indicates that OLIT is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for OLIT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 37.8
ROIC/WACCN/A
WACCN/A
OLIT Yearly LT Debt VS Equity VS FCFOLIT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 0.35 indicates that OLIT may have some problems paying its short term obligations.
  • A Quick Ratio of 0.35 indicates that OLIT may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
OLIT Yearly Current Assets VS Current LiabilitesOLIT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 200K 400K 600K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • OLIT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 214.40%, which is quite impressive.
EPS 1Y (TTM)214.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-286.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 422.00, the valuation of OLIT can be described as expensive.
  • OLIT is valuated expensively when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 422
Fwd PE N/A
OLIT Price Earnings VS Forward Price EarningsOLIT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OLIT Per share dataOLIT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OLIT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

OMNILIT ACQUISITION CORP-A

NASDAQ:OLIT (11/7/2023, 8:14:36 PM)

After market: 9.63 +1.19 (+14.1%)

8.44

+0.5 (+6.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.27%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.82M
Revenue(TTM)N/A
Net Income(TTM)806.89K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 422
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.86
P/tB 3.86
EV/EBITDA N/A
EPS(TTM)0.02
EY0.24%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS2.19
TBVpS2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.66%
ROE 6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 37.8
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)214.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-286.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-160.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-135.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-135.19%
OCF growth 3YN/A
OCF growth 5YN/A

OMNILIT ACQUISITION CORP-A / OLIT FAQ

What is the fundamental rating for OLIT stock?

ChartMill assigns a fundamental rating of 2 / 10 to OLIT.


Can you provide the valuation status for OMNILIT ACQUISITION CORP-A?

ChartMill assigns a valuation rating of 0 / 10 to OMNILIT ACQUISITION CORP-A (OLIT). This can be considered as Overvalued.


How profitable is OMNILIT ACQUISITION CORP-A (OLIT) stock?

OMNILIT ACQUISITION CORP-A (OLIT) has a profitability rating of 0 / 10.


How financially healthy is OMNILIT ACQUISITION CORP-A?

The financial health rating of OMNILIT ACQUISITION CORP-A (OLIT) is 5 / 10.